Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

therapeutic invariant natural killer T cells

A preparation of natural killer T cells (NKTs) expressing an invariant (alpha, beta) T-cell receptor (iNKTs), with potential immunomodulating and antineoplastic activities. Upon infusion of the therapeutic iNKTs, these cells recognize CD1d-restricted lipid ligands, which are expressed on certain tumor cells, and secrete large amounts of various cytokines. This may activate the immune system against tumor cells. Additionally, iNKTs directly target and lyse tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:therapeutic iNK T cells
therapeutic iNKT
therapeutic iNKT cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search